Clinical trials: Epilepsies

Epilepsy

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

• Completed
• Age: 16 to 70 years
• Phase 3
• Results posted

This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the…

Trial name

NCT00530855

Testing

Lacosamide

Where

108 sites in United States, Australia and 7 more

Volunteers

322 people

Sponsor

UCB Pharma